معرفی
Lucy Finnigan is a Postdoctoral Researcher at the University of Oxford's Oxford Centre for Clinical Magnetic Resonance Research (OCMR). Her work focuses on advancing magnetic resonance imaging (MRI) techniques to study disease progression in cardiovascular and post-COVID-19 conditions. She holds a PhD from Liverpool John Moores University and Alder Hey Children’s Hospital, where she investigated cerebral perfusion during pediatric cardiac surgeries.
Her research interests include novel MRI applications for hypertrophic cardiomyopathy (HCM) and Long COVID. Notably, she led a clinical trial evaluating mitochondrial function restoration in Long COVID patients, representing the first randomized, double-blind intervention for fatigue in this population. She has contributed to high-impact studies like the C-MORE cohort analyzing multiorgan MRI outcomes post-COVID-19 hospitalization and the PHOSP-COVID initiative exploring long-term post-acute sequelae.
Lucy’s publications span cardiovascular imaging, mitochondrial dysfunction assessment via MR spectroscopy, and ECG-driven cardiac injury screening. Her work bridges translational research and clinical practice, particularly in optimizing MRI protocols for early disease detection and therapeutic monitoring.
Her research group collaborations include the Neubauer Group at OCMR and multi-institutional projects like the PHOSP-COVID consortium. While currently focused on postdoctoral research, her prior studies on extracorporeal circulation’s effects on neonatal cerebral perfusion highlight her interdisciplinary approach to cardiovascular and critical care challenges.
